Overview

New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma

Status:
Unknown status

Trial end date:
2012-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and tolerability of the combination chemotherapy of L-asparaginase plus DICE regimen in the patients with early stage NK/T-cell lymphoma.

Phase:

Phase 2

Details

Lead Sponsor:

Fudan University

Treatments:

Asparaginase